Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|8|922-931

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.8, 2010-12, pp. : 922-931

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of B-Cell Activation by Complement Receptors CD21 and CD35

By  

Current Pharmaceutical Design, Vol. 9, Iss. 23, 2003-09 ,pp. : 1849-1860

Bentham Science Publishers

Access to resources Recommend Favorite

The binding of mannan binding lectin parallels the expression of complement receptor 1 (CR1, CD35) on erythrocytes and neutrophils

By Ghiran I.   Barbashov S.   Klickstein L.   Nicholson-Weller A.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 86-86

Elsevier

Access to resources Recommend Favorite

The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells

By Lees D.M.   Pallikaros Z.   Corder R.  

European Journal of Pharmacology, Vol. 390, Iss. 1, 2000-02 ,pp. : 89-94

Elsevier

Access to resources Recommend Favorite

Characterization of human membrane cofactor protein (MCP, CD46) on spermatozoa

By Kemper C.   Riley R.C.   Leung M.   Atkinson J.P.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 66-66

Elsevier

Access to resources Recommend Favorite

Development of a membrane-targeted complement inhibitor for clinical use

By Dodd I.   Oldroyd R.G.   Powell S.   Affleck L.J.   Bamber L.   Gallagher S.   Rowling P.J.E.   Ragnauth C.   Smith G.P.   Pratt J.R.   Sacks S.H.   Linton S.M.   Morgan B.P.   Smith R.A.G.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 63-63

Elsevier

Access to resources Recommend Favorite